AAAAAA

   
Results: 1-8 |
Results: 8
FLEXION CONTRACTURES ASSOCIATED WITH A MALIGNANT NEOPLASM - A PARANEOPLASTIC-SYNDROME
Authors: EEKHOFF EMW VANDERLUBBE PA BREEDVELD FC
Citation: Emw. Eekhoff et al., FLEXION CONTRACTURES ASSOCIATED WITH A MALIGNANT NEOPLASM - A PARANEOPLASTIC-SYNDROME, Clinical rheumatology, 17(2), 1998, pp. 157-159
TREATMENT WITH A CHIMERIC CD4 MONOCLONAL-ANTIBODY IS ASSOCIATED WITH A RELATIVE LOSS OF CD4(+) CD45RA(+) CELLS IN PATIENTS WITH RHEUMATOID-ARTHRITIS/
Authors: VANDERLUBBE PA BREEDVELD FC TAK PP SCHANTZ A WOODY J MILTENBURG AMM
Citation: Pa. Vanderlubbe et al., TREATMENT WITH A CHIMERIC CD4 MONOCLONAL-ANTIBODY IS ASSOCIATED WITH A RELATIVE LOSS OF CD4(+) CD45RA(+) CELLS IN PATIENTS WITH RHEUMATOID-ARTHRITIS/, Journal of autoimmunity, 10(1), 1997, pp. 87-97
MONOCLONAL-ANTIBODY THERAPY OF INFLAMMATORY RHEUMATIC DISEASES
Authors: BREEDVELD FC VANDERLUBBE PA
Citation: Fc. Breedveld et Pa. Vanderlubbe, MONOCLONAL-ANTIBODY THERAPY OF INFLAMMATORY RHEUMATIC DISEASES, British Medical Bulletin, 51(2), 1995, pp. 493-502
IMMUNOLOGICAL EFFECTS OF A CHIMERIC CD4 MONOCLONAL-ANTIBODY (CM-T412)IN PATIENTS WITH EARLY RHEUMATOID-ARTHRITIS
Authors: VANDERLUBBE PA MILTENBURG AM TAK PP SCHANTZ A BIJL J BREEDVELD FC
Citation: Pa. Vanderlubbe et al., IMMUNOLOGICAL EFFECTS OF A CHIMERIC CD4 MONOCLONAL-ANTIBODY (CM-T412)IN PATIENTS WITH EARLY RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 38(9), 1995, pp. 194-194
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CD4 MONOCLONAL-ANTIBODY THERAPY IN EARLY RHEUMATOID-ARTHRITIS
Authors: VANDERLUBBE PA DIJKMANS BAC MARKUSSE HM NASSANDER U BREEDVELD FC
Citation: Pa. Vanderlubbe et al., A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CD4 MONOCLONAL-ANTIBODY THERAPY IN EARLY RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 38(8), 1995, pp. 1097-1106
REDUCTION OF SYNOVIAL INFLAMMATION AFTER ANTI-CD4 MONOCLONAL-ANTIBODYTREATMENT IN EARLY RHEUMATOID-ARTHRITIS
Authors: TAK PP VANDERLUBBE PA CAULI A DAHA MR SMEETS TJM KLUIN PM MEINDERS AE YANNI G PANAYI GS BREEDVELD FC
Citation: Pp. Tak et al., REDUCTION OF SYNOVIAL INFLAMMATION AFTER ANTI-CD4 MONOCLONAL-ANTIBODYTREATMENT IN EARLY RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 38(10), 1995, pp. 1457-1465
TREATMENT OF RHEUMATOID-ARTHRITIS WITH A CHIMERIC CD4 MONOCLONAL-ANTIBODY (CM-T412) - IMMUNOPHARMACOLOGICAL ASPECTS AND MECHANISMS OF ACTION
Authors: VANDERLUBBE PA REITER C MILTENBURG AM KRUGER K DERUYTER AN RIEBER EP BIJL JA RIETHMULLER G BREEDVELD FC
Citation: Pa. Vanderlubbe et al., TREATMENT OF RHEUMATOID-ARTHRITIS WITH A CHIMERIC CD4 MONOCLONAL-ANTIBODY (CM-T412) - IMMUNOPHARMACOLOGICAL ASPECTS AND MECHANISMS OF ACTION, Scandinavian journal of immunology, 39(3), 1994, pp. 286-294
CHIMERIC CD4 MONOCLONAL-ANTIBODY CM-T412 AS A THERAPEUTIC APPROACH TORHEUMATOID-ARTHRITIS
Authors: VANDERLUBBE PA REITER C BREEDVELD FC KRUGER K SCHATTENKIRCHNER M SANDERS ME RIETHMULLER G
Citation: Pa. Vanderlubbe et al., CHIMERIC CD4 MONOCLONAL-ANTIBODY CM-T412 AS A THERAPEUTIC APPROACH TORHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 36(10), 1993, pp. 1375-1379
Risultati: 1-8 |